Andrew Ferguson, the chair of the Federal Trade Commission, has decided to rejoin the agency’s lawsuit against major pharmacy benefit managers, allowing the case to move forward and resuscitating a major challenge to the drug middlemen. The FTC paused the litigation against CVS’ Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx, saying it didn’t have enough commissioners to try the case after President Donald Trump fired two Democrats last month. Ferguson and the other Republican commissioner, Melissa Holyoak, were both recused from the case. But “I have decided to no longer recuse myself from the matter to ensure that the case can continue,” Ferguson said in a post on social media site X.
Read the full article: FTC Lawsuit Against PBMs Can Move Forward After Ferguson Rejoins Case //
Source: https://www.healthcaredive.com/news/ftc-pbm-case-move-forward-ferguson/744454/